Abstract:COVID‐19 has been proposed to facilitate reactivation of pulmonary tuberculosis (TB) via immune‐dysregulation and local effects. The present study aimed to explore the possibility of such an association among patients diagnosed with TB using a case‐control design. Our findings suggest a link between prior history of COVID‐19 infection and the development of TB. Objective To assess the risk of developing pulmonary tuberculosis (TB) in accordance with prior history of COVID‐19 infection. Background Since the advent of the COVID‐19 pandemic much discussion has been had on the possible role it might play on global efforts to combat TB; most, focusing on the pandemic's impact on health care systems' capabilities to manage TB cases. Mechanisms have also been proposed by which the COVID‐19 infection may directly affect individuals' chance of developing TB infection. Cases have been reported with a history of COVID‐19 infection preceding a diagnosis of TB, evidencing its possible role as a risk factor for the disease. Methods A case‐control study was conducted enrolling patients diagnosed with pulmonary TB in the absence of major risk factors previous history of TB, (HIV) human immunodeficiency virus infection), end‐stage renal disease, organ transplants, and use of immunosuppressive agents) for developing TB. Each patient was age and sex matched with one healthy control. Data regarding prior COVID‐19 infection, diabetes, and smoking status as well as the use of corticosteroids and Tocilizumab for the treatment of COVID‐19 infection was obtained. Bivariate analysis was conducted and variables with a likely association with TB status were entered in a multivariate model. Results Bivariate analysis demonstrated a significant relationship between prior COVID‐19 infection and TB (95% confidence interval = 1.1−22.8, odds ratio [OR] = 5). Among other variables the severity of COVID‐19 infection was found to have a likely association with TB status (p = .125). In a multivariate model, prior COVID‐19 infection per se, was not found to be significantly associated with TB (p = .12, OR = 4.5). Conclusions There seems to be an association between prior history of COVID‐19 and a future diagnosis of TB partially linked to the severity of disease. The findings of the current study may serve as a basis for further studies to determine the need for and efficacy of measures to follow‐up COVID‐19 patients at an increased risk for developing TB.

Previous pulmonary tuberculosis enhances the risk of lung cancer: systematic reviews and meta-analysis

Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study

Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis

Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort Study

Risk Factors for Pulmonary Tuberculosis in Patients with Lung Cancer: A Retrospective Cohort Study

Prior COVID‐19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case‐control study

Increased Incidence of Severe Adverse Events in Non-Small Cell Lung Cancer Patients with Previous Tuberculosis Episode Treated with PD-1 Inhibitors

Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation

Effects of low dose computed tomography (LDCT) on lung cancer screening on incidence and mortality in regions with high tuberculosis prevalence: A systematic review

Associations of prior pulmonary tuberculosis with the incident COPD: a prospective cohort study

The burden of tuberculosis among patients with non-small cell lung carcinoma in a tertiary care center

Cancer risk in tuberculosis patients in a high endemic area

Impact of Prior Cancer History on Outcomes of Resected Lung Cancer

O-327 ASSOCIATION OF TUBERCULOSIS WITH LUNG FUNCTION IMPAIRMENT IN WORKERS WITH SILICOSIS: A LONGITUDINAL STUDY FROM 1981 TO 2019

The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study

New progress of tuberculosis scar carcinoma

Smoking and tuberculosis among silicotic patients

[Progress and challenges in clinical diagnosis and treatment of co-existent lung cancer and pulmonary tuberculosis]

The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis

The risk and prognostic factors for pulmonary tuberculosis complicated with carcinoma